Study Evaluating REVLIMID® Combination Compared to Autologous Stem Cell ... Business Wire (press release) ... today announced data from a study comparing melphalan, prednisone and REVLIMID (lenalidomide) (MPR) with high-dose chemotherapy and tandem autologous stem cell transplant (MEL200), as well as evaluating the effect of lenalidomide maintenance ... ASCO 2013 Multiple Myeloma Update – Day Two: Education Session |
